Monthly Archives: May, 2023

Browse our exclusive articles!

MediaTek Leverages Nvidia GPU and AI for Connected Car Chipsets

MediaTek and Nvidia partner to create new AI-driven hardware & software for cars, set to launch in 2025. Products to cover all vehicle sectors.

Exploring Machine Learning for Rare Diseases: A Study Using Nature Methods

This article focuses on how machine learning can help us understand rare diseases, especially with limited sample sizes. We discuss specific challenges, potential solutions, and the need for ML techniques to be further developed for such cases. Our aim is to advance rare diseases research and broaden the use of ML in high-dimensional datasets with few samples.

Global Generative AI Market Forecast: Software Transformative Models (GPT-1, GPT-2, GPT-3, GPT-4, LAMBDA) and Services with CAGR of 35.6% to 2028

The generative AI market is set to skyrocket, reaching USD 51.8 billion by 2028 from USD 11.3 billion in 2023. Key drivers include AI and deep learning advancements, streamlined data accessibility, and content creation. Managed services lead the race, while the media and entertainment industry shows the fastest growth rate. North America leads the market, followed by Europe and Asia-Pacific.

Nvidia CEO States Artificial Intelligence Can Enable Everyone to Become a Programmer and Bridge Digital Gap

Nvidia CEO claims AI tools have opened up programming to everyone, regardless of skill level. They've bridged the digital divide, but there are concerns about job losses.

All the News from Taiwan’s Big PC Show – Computex 2023

Computex 2023 is back as an in-person event, featuring big names in the PC and laptop industry from Taiwan and beyond. Expect product launches and updates in the tech space at this exciting event.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img